Washington Wins $900 Million Opioid Verdict Against Albertsons

A King County Superior Court judge ordered Albertsons to pay Washington state $900 million on Thursday, ruling that the grocery chain's pharmacies failed to guard against the misuse and diversion of controlled substances for sixteen years. Attorney General Nick Brown said the judgment, plus fees and costs, is believed to be the largest verdict in Washington history.

Judge Janet Helson issued the ruling after a nine-week trial in Seattle. It closes a case the attorney general's office filed in 2022 against several national pharmacy chains; Albertsons was the last defendant standing, because the others settled early or went bankrupt.

What the state proved

Between 2006 and 2022, Albertsons pharmacies dispensed more than 641 million opioid pills into Washington, according to the attorney general's office. The state argued that most of those orders carried "red flags of diversion" — signals that a prescription might be misused or resold — and that pharmacists were expected to investigate those signals and document what they found.

The judgment turns on the documentation. Albertsons, the state showed, filled red-flagged opioid prescriptions more than 6.5 million times without recording any effort to confirm that a prescriber had written them for a legitimate medical purpose. Albertsons operates more than 200 pharmacies in Washington under its Albertsons, Safeway and Haggen banners.

The attorney general's office said the ruling established that Albertsons violated the law and failed to guard against the misuse and diversion of dangerous controlled substances.

State lawyers also presented internal evidence that corporate policy pushed pharmacists away from gatekeeping. According to the release, Albertsons discouraged staff from flagging problem prescribers, did not let some pharmacists refuse prescriptions from known pill-mill doctors that competing chains had already blocked, and kept store-level data siloed so pharmacists could not compare notes across locations. The company continued accepting discount cards for controlled substances after other chains stopped, because the cards let patients avoid insurer scrutiny; internal documents described card users arriving as "refugees" from other pharmacies.

Staffing was part of the case. State lawyers read emails in which Albertsons pharmacists wrote that it was "impossible" to review prescriptions properly given their workload, and described vomiting "due to exhaustion, dehydration, and hunger" and "breaking down in tears in the back." One warned the company that under those conditions "mistakes can easily be made to put someone's life at risk."

The state also documented theft from under-monitored inventories: an employee at a Safeway in North Bend stole more than 70,000 opioid pills over two years before being caught, with smaller losses of 12,000 pills in Leavenworth and 19,000 in Olympia.

The numbers behind the case

More than 26,000 Washington residents have died of opioid overdose since 1999, and roughly 7,400 in the past three years, according to state figures cited in the release. Research cited by the attorney general's office suggests about ten times as many people were living with opioid use disorder in 2023 alone as have died since 1999.

"This is a victory for the people of Washington. When giant corporations put profits above safety, they will be held accountable," Brown said in the release. "This verdict can't undo the devastating harms of the opioid crisis, but it will provide desperately needed resources to support treatment and prevent future crises." Speaking to reporters after the ruling, he framed it more broadly: "when corporations put safety measures at risk, when they do not prioritize their customers, when they are not focused on safety, that they will be held accountable."

The money adds to the $2.17 billion the office says it has recovered for state and local governments from opioid manufacturers, distributors and pharmacies since the crisis began. Those dollars are directed to opioid abatement, which in Washington means medication-assisted treatment, naloxone distribution and local prevention programs.

Albertsons says it may appeal

The company said it was "disappointed by the court's ruling" and that it "respectfully disagrees with its conclusions." In its statement, Albertsons added that it is "reviewing the decision closely" and will "evaluate all available options, including appeal."

That means the $900 million is unlikely to reach state coffers soon. Washington State Standard noted the appeals process will delay disbursement.

Albertsons has been settling opioid claims elsewhere. In April it agreed to pay $773.8 million to resolve litigation brought by states and subdivisions that joined the national framework — a deal Washington declined, opting instead for trial.

Why pharmacy liability matters for treatment

Retail pharmacies were the last checkpoint before prescription opioids reached patients, and the legal theory tested in Seattle — that chains had an affirmative duty to investigate red flags rather than fill orders — has been pursued in only a handful of cases to judgment. Most chains settled. Washington's win gives other states and cities a proven trial record to point to when negotiating with the remaining defendants.

For patients, the practical effect runs through funding. Washington's abatement dollars already pay for opioid treatment programs and outpatient care, and the attorney general's office says the verdict "will expand treatment and prevention resources throughout Washington." Public money is a main route to care for people without insurance; those looking for help can start with opioid rehab programs or call the SAMHSA National Helpline at 1-800-662-4357.

The verdict itself is posted by the attorney general's office, which also covered the opening of the trial when Washington took Albertsons to court in July.